<DOC>
	<DOCNO>NCT02060162</DOCNO>
	<brief_summary>This study aim establish cohort patient start antiretroviral therapy ( ART ) chronic hepatitis B virus ( HBV ) infection study effect chronic HBV HIV- liver-related outcome accord ART regimen site .</brief_summary>
	<brief_title>Antiretroviral Treatment Outcomes HIV-HBV Co-infected Patients Southern Africa</brief_title>
	<detailed_description>The study take place routinely schedule ART visit per Ministry Health guideline . Routinely collect programmatic data use assess general HIV outcome ( CD4 response , loss follow-up , death ) well collect study specific data ( hepatitis testing , questionnaire regard risk factor hepatitis/liver disease , non-invasive liver scan ) address aim . The study implement two site Southern Africa total enrollment across site 1,900 participant . The Zambia site enroll 900 .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>HIVinfected Male female age ≥18 year ART naïve ART eligible define Zambian WHO treatment guideline Initiating ART regimen include least 3 drug one study sit . Willing provide sign informed consent follow clinical site . Patients plan remain catchment area recruit duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>antiretroviral therapy</keyword>
	<keyword>Hepatitis C virus</keyword>
</DOC>